MENU
+Compare
CDXS
Stock ticker: NASDAQ
AS OF
May 8 closing price
Price
$2.46
Change
+$0.18 (+7.89%)
Capitalization
188.89M

CDXS Codexis Forecast, Technical & Fundamental Analysis

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes... Show more

CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CDXS with price predictions
May 07, 2025

CDXS in +9.56% Uptrend, advancing for three consecutive days on May 02, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CDXS advanced for three days, in of 285 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CDXS's RSI Indicator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 29, 2025. You may want to consider a long position or call options on CDXS as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CDXS just turned positive on April 11, 2025. Looking at past instances where CDXS's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where CDXS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 50-day moving average for CDXS moved below the 200-day moving average on April 01, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CDXS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CDXS broke above its upper Bollinger Band on May 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CDXS entered a downward trend on April 04, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.791) is normal, around the industry mean (14.238). P/E Ratio (0.000) is within average values for comparable stocks, (62.770). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.866). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (2.789) is also within normal values, averaging (252.967).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CDXS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CDXS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CDXS is expected to report earnings to rise 82.08% to -23 cents per share on May 14

Codexis CDXS Stock Earnings Reports
Q1'25
Est.
$-0.24
Q4'24
Missed
by $0.09
Q3'24
Missed
by $0.05
Q2'24
Missed
by $0.06
Q1'24
Beat
by $0.02
The last earnings report on February 27 showed earnings per share of -12 cents, missing the estimate of -3 cents. With 491.36K shares outstanding, the current market capitalization sits at 188.89M.
A.I. Advisor
published General Information

General Information

a developer of biocatalytic chemical processes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Chemicals Specialty
Address
200 Penobscot Drive
Phone
+1 650 421-8100
Employees
174
Web
https://www.codexis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SXPRX46.320.26
+0.56%
DWS S&P 500 Index R6
JLVZX19.40N/A
N/A
JPMorgan Large Cap Value R2
AIOCX8.64N/A
N/A
American Century International Opps C
LGCRX17.04N/A
N/A
Lord Abbett Global Equity R3
UIVIX11.79N/A
N/A
MFS Intrinsic Value I

CDXS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CDXS has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CDXS jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDXS
1D Price
Change %
CDXS100%
+7.89%
DNLI - CDXS
49%
Loosely correlated
+0.77%
ABCL - CDXS
46%
Loosely correlated
N/A
BEAM - CDXS
46%
Loosely correlated
+6.32%
PRAX - CDXS
45%
Loosely correlated
-0.08%
XENE - CDXS
45%
Loosely correlated
+0.59%
More